- Filed
- Apr 29, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Apr 27, 2026 | 45.93M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 46.35M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 49.45M sh |
| Stock Repurchased | Q1 2026 · Mar 31, 2026 | $82.1M |
| Stock Repurchased | Q1 2026 · Mar 31, 2025 | $100.03M |
| Capex | Q1 2026 · Mar 31, 2026 | $1.67M |
| Capex | Q1 2026 · Mar 31, 2025 | $688K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $51.46M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $1.39M |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $1.16B |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $1.09B |
| Short Term Debt | Q1 2026 · Mar 31, 2026 | $23.16M |
| Short Term Debt | Q1 2026 · Dec 31, 2025 | $22.66M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $34.1M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $38.91M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $34.55M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $85.05M |
| Stockholders Equity restated | Q1 2026 · Mar 31, 2025 | $17.48M |
| Stockholders Equity restated | Q1 2026 · Dec 31, 2024 | $126.84M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $866.68M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $1.18B |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $2.07B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $2.31B |
| Current Assets | Q1 2026 · Mar 31, 2026 | $642.22M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $930.09M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $2.11B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $2.39B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.67 |
| Eps Diluted restated | Q1 2026 · Mar 31, 2025 | $0.09 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.68 |
| Eps Basic restated | Q1 2026 · Mar 31, 2025 | $0.09 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $30.26M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $56.68M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $36.92M |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $33.56M |
| Net Income | Q1 2026 · Mar 31, 2026 | $31.14M |
| Net Income restated | Q1 2026 · Mar 31, 2025 | $4.32M |
| Operating Income | Q1 2026 · Mar 31, 2026 | $51.45M |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | $19.71M |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $166.56M |
| Gross Profit restated | Q1 2026 · Mar 31, 2025 | $155.12M |
| Revenue | Q1 2026 · Mar 31, 2026 | $281.14M |
| Revenue restated | Q1 2026 · Mar 31, 2025 | $269.94M |